Improvements in Treating Ph-like ALL, Trials in Pre B-ALL & Blinatumomab for MRD-Positive ALL
By
Indy Hematology Review
FEATURING
Hagop Kantarjian
By
Indy Hematology Review
FEATURING
Hagop Kantarjian
Login to view comments.
Click here to Login